Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Health
News by Topic: Healthcare business and finance

Jun 18, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on revisions to an information collection titled "Submission of 1135 Waiver Request Automated Process." CMS aims to better support emergency response by capturing the emergency date, simplifying ongoing status updates for stakeholders, and providing a more comprehensive view of cybersecurity incidents through expanded reporting on patient and operational impacts. The Acute Hospital Care at Home (AHCAH) initiative was codified in the Consolidate Appropriations Act, 2025, and is no longer part of the 1135 waiver information collection request. Comments are due by July 20, 2026.
Source: Federal Register
Jun 18, 2026 - The Centers for Medicare & Medicaid Services (CMS) is seeking comments on a request for information (RFI) regarding technical input on the services and business practices of pharmacy benefit managers (PBMs) and their affiliates to inform implementation of recent legislation. The RFI specifically focuses on two specific legislative requirements that are effective beginning calendar year 2028: 1) restrictions on the remuneration that PBMs and their affiliates may receive for services in connection with the utilization of covered Part D drugs and 2) data reporting requirements. Comments are due by July 20, 2026.
Source: Federal Register
Jun 16, 2026 - The Centers for Medicare & Medicaid Services is seeking comments on the following information collections: 1) Conditions of Coverage for Portable X-ray Suppliers and Supporting Regulations; and 2) Requirements Related to Surprise Billing; Part II. Comments are due by July 16, 2026.
Source: Federal Register
Jun 16, 2026 - Notice of proposed rule from the Centers for Medicare & Medicaid Services (CMS) that would codify the Medicare Drug Price Negotiation Program, establish certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022, and propose a modification to the fixed combination drug policy. Comments are due by August 17, 2026.
Source: Federal Register
Jun 16, 2026 - Notice of final rule with comment period from the Centers for Medicare & Medicaid Services (CMS) establishing provisions to strengthen the oversight of Medicare national accrediting organizations by addressing conflicts of interest; establishing consistent standards, processes, and definitions; and updating the validation and performance standards systems. In addition, this rule revises the psychiatric hospital survey process, adds a limitation on terminated deemed providers and suppliers when reentering the program, and provides technical corrections for End-Stage Renal Disease (ESRD) facilities and Transplant Programs. This rule is effective June 16, 2027. Comments are due by August 17, 2026.
Source: Federal Register
Jun 15, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking public input regarding its comprehensive review of the Essential Health Benefits (EHB) framework and the requirement that the scope of EHB be equal to the scope of benefits provided under a typical employer plan. Among other things, CMS seeks comments on current interpretations of EHB, state approaches to selecting and updating EHB-benchmark plans, methodologies used to determine the scope of benefits included as EHB, and how these approaches relate to access and market stability under the Patient Protection and Affordable Care Act. Comments are due by July 15, 2026.
Source: Federal Register
Jun 15, 2026 - Notice from the Health Resources and Services Administration (HRSA) seeking comments on a proposed information collection request (ICR) titled "340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB No. 0906-NEW." HRSA's Office of Pharmacy Affairs (OPA) intends to introduce a revised 340B Rebate Model Pilot Program (Pilot) as a mechanism for qualifying drug manufacturers, who wish to participate, to effectuate the 340B ceiling price on a limited set of drugs sold to covered entities using rebates. This ICR includes the collection of proposed rebate model plans from qualifying drug manufacturers, the ongoing collection of sales data from drug manufacturers to allow OPA to monitor implementation of the Pilot and enhance 340B program integrity and compliance monitoring, and the collection of data submitted by covered entities to manufacturers to request a rebate under a potential Pilot. Comments are due by July 15, 2026.
Source: Federal Register
Jun 11, 2026 - Describes a planned notice of proposed rulemaking regarding budget neutrality standards for Medicaid section 1115 demonstrations. The new standard is expected to be in effect on or after January 1, 2027. States with demonstrations up for renewal in 2027 may be required to take additional steps in the renewal process. More information will be released in future rulemaking.
Source: Centers for Medicare & Medicaid Services Newsroom
Jun 11, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) establishing the CMS Office of Health Technology and Products (OHTP). OHTP will provide enterprise leadership and oversight for CMS healthcare technology modernization, digital products, and transformation of platforms and services supporting Medicare, Medicaid, the Children's Health Insurance Program (CHIP), and other CMS-administered programs. This organizational change was effective June 9, 2026.
Source: Federal Register
Jun 10, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on the reinstatement with change of an information collection titled "Generic Clearance for the Collection of Qualitative Feedback." Information collected will be used to ensure that CMS customers and stakeholders have effective, efficient, and satisfying experiences with CMS's programs. Comments are due by August 10, 2026.
Source: Federal Register